Familial idiopathic hyper-CK-emia: An underrecognized condition

Muscle and Nerve

Volumn 33, Issue 6, 2006, Pages 760-765

  Capasso, Margherita ^a   De Angelis, Maria Vittoria ^a   Di Muzio, Antonio ^a   Scarciolla, Oronzo ^a   Pace, Marta ^a   Stuppia, Liborio ^a   Comi, Giacomo Pietro ^b   Uncini, Antonino ^a  

^a UNIVERSITY OF CHIETI   (Italy)

^b UNIVERSITY OF MILAN   (Italy)

Author keywords

Caveolin 3; Familial idiopathic hyperCKemia; Morphometry; Muscle biopsy; Serum creatine kinase

Indexed keywords

CAVEOLIN 3; CREATINE KINASE;

ADOLESCENT; ADULT; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CELL SIZE; CLINICAL ARTICLE; CREATINE KINASE BLOOD LEVEL; FAMILIAL DISEASE; FAMILIAL IDIOPATHIC HYPERCREATINE KINASEEMIA; FAMILY STUDY; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; IDIOPATHIC DISEASE; MALE; MALE TO MALE TRANSMISSION; MOLECULAR GENETICS; MORPHOMETRICS; MUSCLE BIOPSY; MUSCLE FIBER DISTRIBUTION; MUSCLE FIBER SIZE; PEDIGREE; PENETRANCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; VERTICAL TRANSMISSION;

ADOLESCENT; ADULT; AGED; BIOPSY; CAVEOLIN 3; CHILD; CHILD, PRESCHOOL; CREATINE KINASE; FAMILY HEALTH; FEMALE; GENES, DOMINANT; GENETIC PREDISPOSITION TO DISEASE; HUMANS; INFANT; MALE; MIDDLE AGED; NEUROMUSCULAR DISEASES; PEDIGREE; PENETRANCE; PREVALENCE; SEX DISTRIBUTION;

EID: 33744951413     PISSN: 0148639X     EISSN: 10974598     Source Type: Journal    
DOI: 10.1002/mus.20525     Document Type: Article

References (26)

1. Afifi AK. Idiopathic hyperCKemia revisited. J Child Neurol 1998;13:251-252.
2. Alias L, Gallano P, Moreno D, Pujol R, Martinez-Matos JA, Baiget M, et al. A novel mutation in the caveolin-3 gene causing familial isolated hyperCKaemia. Neuromuscul Disord 2004;14:321-324.
3. Brewster LM, de Visser M. Persistent hyperCkemia: fourteen patients studied in retrospect. Acta Neurol Scand 1988;77:60-63.
4. Bruno C, Bertini E, Santorelli FM, Di Mauro S. HyperCKemia as the only sign of McArdle's disease in a child. J Child Neurol 2000;15:137-138.
5. Capasso M, Lupo S, Di Muzio A, Uncini A, Servidei S. Immunohistochemical study of caveolin-3 in idiopathic hyperCKaemia. J Neurol Neurosurg Psychiatry 2003;74:547-548.
6. Carbone I, Bruno C, Sotgia F, Bado M, Broda P, Masetti E, et al. Mutation in the CAV3 gene causes partial caveolin-3 deficiency and hyperCKemia. Neurology 2000;54:1373-1376.
7. Dubowitz V. Definition of pathological changes seen in muscle biopsies. In: Dubowitz V, editor. Muscle biopsy. A practical approach. London: Baillière Tindall; 1985. p 82-128.
8. Frydman M, Straussberg R, Shomrat R, Goebel H, Legum C, Shiloh Y. Duchenne muscular dystrophy and idiopathic hyperCKemia segregating in a family. Am J Med Genet 1995;58:209-212.
9. Fukutake T, Hattori T. Normalization of creatine kinase level during pregnancy in idiopathic hyperCKemia. Clin Neurol Neurosurg 2001;103:168-170.
10. Galassi G, Rowland LP, Hays AP, Hopkins LC, Di Mauro S. High serum levels of creatine kinase: asymptomatic prelude to distal myopathy. Muscle Nerve 1987;10:346-350.
11. Garcia W. Elevated creatine phosphokinase levels associated with large muscle mass. Another pitfall in evaluating clinical significance of total serum CPK activity. JAMA 1974;228:1395-1396.
12. Gronert GA. Malignant hyperthermia. In: Engel AG, Franzini-Armstrong C, editors. Myology, Vol 2. New York: McGraw-Hill; 1994. p 1661-1678.
13. Joy JL, Oh SJ. Asymptomatic hyper-CK-emia: an electrophysiologic and histopathologic study. Muscle Nerve 1989;12:206-209.
14. Merlini L, Carbone I, Capanni C, Sabatelli P, Tortorelli S, Sotgia F, et al. Familial isolated hyperCKaemia associated with a new mutation in the caveolin-3 (CAV-3) gene. J Neurol Neurosurg Psychiatry 2002;73:65-67.
15. Merlini L, Sabatelli P, Columbaro M, Bonifazi E, Pisani V, Massa R, et al. Hyper-CK-emia as the sole manifestation of myotonic dystrophy type 2. Muscle Nerve 2005;31:764-767.
16. Minetti C, Sotgia F, Bruno C, Scartezzini P, Broda P, Bado M, et al. Mutations in the caveolin-3 gene cause autosomal dominant limb-girdle muscular dystrophy. Nat Genet 1998;18:365-368.
17. Prelle A, Rigoletto C, Moggio M, Sciacco M, Comi GP, Ciscato P, et al. Asymptomatic familial hyperCKemia associated with desmin accumulation in skeletal muscle. J Neurol Sci 1996;140:132-136.
18. Prelle A, Sciacco M, Tancredi L, Fagiolari G, Comi GP, Ciscato P, et al. Clinical, morphological and immunological evaluation of six patients with dysferlin deficiency. Acta Neuropathol 2003;105:537-542.
19. Prelle A, Tancredi L, Sciacco M, Chiveri L, Comi GP, Battistel A, et al. Retrospective study of a large population of patients with asymptomatic or minimally symptomatic raised serum creatine kinase levels. J Neurol 2002;249:305-311.
20. Reijneveld JC, Notermans NC, Linssen WHJP, Wokke JHJ. Benign prognosis in idiopathic hyper-CK-emia. Muscle Nerve 2000;23:575-579.
21. Rowland LP, Willner J, Cerri C, Di Mauro S, Miranda A. Approaches to the membrane theory of Duchenne muscular dystrophy. In: Angelini C, Danieli GA, Fontanari D, editors. Muscular dystrophy research: advances and new trends. Amsterdam: Excerpta Medica; 1980. p 3-13.
22. Shumate JB, Brooke MH, Carroll JE, Davis JE. Increased serum creatine kinase after exercise: a sex-linked phenomenon. Neurology 1979;29:902-904.
23. Simmons Z, Peterlin BL, Boyer PJ, Towfighi J. Muscle biopsy in the evaluation of patients with modestly elevated creatine kinase levels. Muscle Nerve 2003;27:242-244.
24. Sunohara N, Takagi A, Nonaka I, Sugita H, Satoyoshi E. Idiopathic hyperCKemia. Neurology 1984;34:544-547.
25. Tateyama M, Aoki M, Nishino I, Hayashi YK, Sekiguchi S, Shiga Y, et al. Mutation in the caveolin-3 gene causes a peculiar form of distal myopathy. Neurology 2002;58:323-325.
26. Vorgerd M, Ricker K, Ziemssen F, Kress W, Goebel HH, Nix WA, et ai. A sporadic case of rippling muscle disease caused by a de novo caveolin-3 mutation. Neurology 2001;57:2273-2277.